CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Equity
Balances, beginning of period (Shares) at Jun. 29, 2019		10,760,000
Balances, beginning of period at Jun. 29, 2019	$ 114,459	$ 46,680	$ 65,353	$ 2,426
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,758		4,758
Unrealized gain (loss) on foreign exchange contracts, net	(3,926)			(3,926)
Share-based compensation expense	266	$ 266
Balances, end of period (Shares) at Jun. 27, 2020		10,760,000
Balances, end of period at Jun. 27, 2020	115,557	$ 46,946	70,111	(1,500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Excess tax benefit from exercise of stock options	0
Net income	4,341		4,341
Unrealized gain (loss) on foreign exchange contracts, net	3,572			3,572
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		2,000
Share-based compensation expense	192	$ 192
Balances, end of period (Shares) at Jul. 03, 2021		10,762,000
Balances, end of period at Jul. 03, 2021	123,705	$ 47,181	74,452	2,072
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Excess tax benefit from exercise of stock options	(43)	43			$ 43
Net income	3,377		3,377
Unrealized gain (loss) on foreign exchange contracts, net	$ (2,497)			(2,497)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0
Share-based compensation expense	$ 293	$ 293
Balances, end of period (Shares) at Jul. 02, 2022		10,762,000
Balances, end of period at Jul. 02, 2022	124,878	$ 47,474	$ 77,829	$ (425)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Excess tax benefit from exercise of stock options	$ 0